341 - CCON SPOTLIGHT: THE STATE OF CARDIO-ONCOLOGY IN CANADA FROM TRAINING TO COMMUNITY PRACTICE

Chair(s)

• 

  Kibar Yared, M.D., F.R.C.P.(C)

  Director, Cardio-Oncology at Scarborough Health Network
  CCON, CSE
  University of Toronto Medical School

Co-Chair(s)

• 

  Amale Ghandour, N.P.

  Nurse Practitioner, University of Montreal
  CCON

Panelist(s)

• ME

  Malak El-Rayes, M.D., F.R.C.P.

  Cardiologist, CSSS de Laval
  CCON
  University of Montreal
• PT

  Paaladinesh Thavendiranathan, MD, SM, FRCPC, FASE

  Director, Ted Rogers Program in Cardiotoxicity Prevention Peter Munk Cardiac Center, Toronto General
  CCON
  University of Toronto

Presenter(s)

• ME

  Malak El-Rayes, M.D., F.R.C.P.

  Cardiologist, CSSS de Laval
  CCON
  University of Montreal
• 

  Margot Davis, MD, MSc, FRCPC (she/her/hers)

  Clinical Assistant Professor, University of British Columbia
  University of British Columbia
  University of British Columbia
• 

  Fernando Rivera-Theurel, M.D.

  Assistant Professor, Clinitian Investigator
  University of Toronto / University Health Network
  University of Toronto

Trainee(s)

• 

  Coralea Kappel, M.D.

  Oncology Resident, Princess Margaret Cancer Center
  CCON
• KW

  Kai Yi Wu, MD, FRCPC

  Adult Cardiology Resident
  University of Alberta
  Mazankowski Alberta Heart Institute

Planning Committee Member(s)

• OC

  Oscar Calvillo-Arguelles, M.D.

  Assistant Professor, NOSM University
  CCON
• 

  Coralea Kappel, M.D.

  Oncology Resident, Princess Margaret Cancer Center
  CCON
• 

  Darryl Leong, M.D, F.R.C.P.C

  Director of the Cardio-Oncology Program at Hamilton Health Sciences
  CCON
  McMaster University
• 

  Negareh Mousavi, M.D.

  Assistant Professor University of McGill
  CCON
  McGill University
• MN

  Michelle Nadler, MD MSc FRCPC

  Assistant Professor, University of Toronto
  CCON
• EP

  Edith Pituskin, RN, MN (NP) PhD

  Associate Professor, Faculty of Nursing
  CCON
• CP

  Coleen Power, N.P

  N.P, Ted Rogers Cardiotoxicity and Prevention Program
  CCON
• 

  Fernando Rivera-Theurel, M.D.

  Assistant Professor, Clinitian Investigator
  University of Toronto / University Health Network
  University of Toronto
• GS

  Guillaume St Pierre, M.D, F.R.C.P.C

  Cardiologue et cardio-oncologue chez CISSS de Chaudière-Appalaches
  CCON
• KW

  Kai Yi Wu, MD, FRCPC

  Adult Cardiology Resident
  University of Alberta
  Mazankowski Alberta Heart Institute

Workshop Description: The Spotlight session will cover three main topics: 1) The current opportunities for Cardio-oncology training / education in Canadafor academic and community physicians and allied health practitioners; 2) The landscape of dedicated Cardio-oncology programs in Canada and how to build one in the community; and 3) Current Canadian clinical trials in Cardio-oncology with opportunity for academic and community program engagement. The session will be presented by experts in the fields of cardiology, oncology, and cardio-oncology.
The main objective of this session is to educate Canadian clinicians on the landscape of cardio-oncology in Canada with focus on (1) providing knowledge as to where to refer patients in academic and community settings for clinical care, (2) opportunities for trainees and practicing clinicians to obtain additional training to either start a career in cardio-oncology or to enhance their current practice, and (3) ongoing clinical trials driven by Canadian clinicians and how to contribute to the development of scientific knowledge from community and academic settings.

Interactive and Engagement Activities Description: The spotlight session will include a panel discussion between experts in the field

Presentations:

• 2:55 PM – 3:00 PM PT

  IS EMPAGLIFLOZIN EQUIVALENT AND/OR SYNERGISTIC WITH ACE INHIBITION IN THE PREVENTION OF CHEMOTHERAPY MEDIATED CARDIOTOXICITY?
  

  Presenter: Tim Rozovsky, Bkin (Hons) – University of Manitoba